Regeneron Pharmaceuticals
The Associate Director role supports PK and PK/PD requirements for early-stage drug discovery and IND projects, providing oversight for preclinical in vivo studies and managing nonclinical PK studies. This position involves analyzing and presenting PK/PD data to project teams and senior management while preparing summary reports for regulatory submissions. The role requires serving as a subject matter expert to guide the design of preclinical studies and collaborate with various internal groups to develop and execute PK strategies.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Scientist/Senior Scientist
ASTARPRD
Scientist IV Pharmacology Contractor
Qpex Biopharma
PK/PD Principal Scientist
Zoetis
Senior Advisor - PK/PD & Pharmacometrics Project Leader
Eli Lilly and Company
Senior Director, Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB)
Merck & Co., Inc.
Senior Scientist I
Exelixis